Pura Vida Investments’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-6,000
Closed -$3.51M 195
2022
Q3
$3.51M Sell
6,000
-3,444
-36% -$2.06M 0.2% 108
2022
Q2
$5.15M Buy
9,444
+7,644
+425% +$3.87M 0.3% 87
2022
Q1
$1.14M Sell
1,800
-7,448
-81% -$3.84M 0.04% 181
2021
Q4
$6.24M Sell
9,248
-8,648
-48% -$5.26M 0.23% 101
2021
Q3
$11.7M Buy
17,896
+2,538
+17% +$2.17M 0.36% 74
2021
Q2
$15.6M Buy
+15,358
New +$13.5M 0.48% 45

Other funds holding AGL

Pura Vida Investments's AGL Position: Q4 2022 in Review

Pura Vida Investments sold out of Agilon Health (AGL) in Q4 2022, closing a stake of 6,000 shares — an estimated $3.51M sold.

Pura Vida Investments first reported a position in AGL in Q2 2021 and held it in 6 quarters. The position peaked at $15.6M in Q2 2021. 166 funds tracked by Wall St. Rank hold AGL as of Q4 2022.

  • Pura Vida Investments reported no remaining Agilon Health position as of Q4 2022 after selling out during the quarter.
  • Pura Vida Investments sold 6,000 Agilon Health shares in Q4 2022, an estimated $3.51M.
  • Pura Vida Investments first reported a position in Agilon Health in Q2 2021 and held it in 6 quarters.
  • Pura Vida Investments's Agilon Health position peaked at $15.6M in Q2 2021.
  • 166 funds tracked by Wall St. Rank held Agilon Health as of Q4 2022.

Based on Pura Vida Investments's 13F filing for Q4 2022, filed 14 Feb 2023.